<DOC>
	<DOCNO>NCT00717275</DOCNO>
	<brief_summary>The purpose study determine administer temozolomide completion stereotactic radiosurgery help control exist brain metastasis prevents developement new brain metastasis .</brief_summary>
	<brief_title>Study Temozolomide Treat Newly Diagnosed Brain Metastases</brief_title>
	<detailed_description>Brain metastasis represent heterogenous group system tumor whose presence central nervous system result profound neurological devastation . Existing therapy brain metastasis focus improve neurologic function survival . Therapies aim control tumor site brain metastasis rest brain potential improve outcome quality life . The combined use stereotactic radiosurgery follow temozolomide may represent strategy .</detailed_description>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Neoplasms , Second Primary</mesh_term>
	<mesh_term>Brain Neoplasms</mesh_term>
	<mesh_term>Temozolomide</mesh_term>
	<mesh_term>Dacarbazine</mesh_term>
	<criteria>Tumor characteristic adequate stereotactic radiosurgery : 1 . 13 newly diagnose , previously untreated , brain metastasis 2 . Each tumor measure size le equal 3 cm 3 . No contraindication stereotactic radiosurgery Systemic parameter adequate temozolomide follow stereotactic radiosurgery : 1 . Histological confirmation systemic malignancy ( brain confirmation require ) 2 . Male female 18 year age old 3 . Negative pregnancy test ( childbearing potential ) 4 . Any number previous recurrence allow 5 . Karnofsky Performance Status &gt; 60 6 . Hematocrit &gt; 30,000 7 . White blood cell count &gt; 1,500 8 . Platelet &gt; 100,000 9 . Absolute Neutrophil Count &gt; 1,000 10 . Bilirubin &lt; 1.5 x upper limit normal 11 . Transaminases ( ALT AST ) &lt; 1.5 x upper limit normal 12 . Creatinine &lt; 1.5 x upper limit normal 13 . Adequate medical health participate study 14 . Adequate documentation menopause ( natural/surgical ) patient commitment routine use reliable birth control ( barrier/hormonal ) 15 . Ability read understand inform consent document 16 . Ability willingness follow requirement study include follow direction , take medication prescribe complete diary form 17 . No contraindication temozolomide ( severe organ dysfunction , immunosuppression , etc . ) 18 . Medical stability and/or recovery effect stereotactic radiosurgery 1 . Karnofsky Performance Status &lt; 60 2 . Hematocrit &lt; 30,000 3 . White blood cell count &lt; 1,500 4 . Platelet &lt; 100,000 5 . Absolute Neutrophil Count &lt; 1,000 6 . Bilirubin &gt; 1.5 x upper limit normal 7 . Transaminases ( ALT AST ) &gt; 1.5 x upper limit normal 8 . Creatinine &gt; 1.5 x upper limit normal 9 . Inability undergo gadoliniumcontrasted MRIs , include severe claustrophobia insufficient allergy prophylaxis 10 . Germ cell , leukemia , lymphoma histology exclude 11 . Prior chemotherapy radiotherapy brain metastasis ( prior resection steroid allow ) 12 . Contraindications radiosurgery temozolomide chemotherapy 13 . Uncontrolled systemic malignancy 14 . Chemotherapy systemic therapy systemic malignancy within specified time temozolomide initiation , depend halflife agent : 1 . Cytotoxic chemotherapy within previous 4 week 2 . Nitrosurea ( CCNU , BCNU ) within previous 6 week 3 . Gliadel temozolomide within previous 4 week 4 . Bevacizumab antiangiogenic agent within previous 4 week 5 . Other target molecular antibody agent within previous 4 week 6 . Hormonal agent within previous 2 week</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>Brain Metastases</keyword>
	<keyword>Temozolomide</keyword>
	<keyword>Temodar</keyword>
	<keyword>TMZ</keyword>
	<keyword>Stereotactic Radiosurgery</keyword>
	<keyword>SRS</keyword>
</DOC>